Following 4 Stocks Remained Under Bearish Claws Thursday - Comstock Resources, (NYSE:CRK), Arch Coal, (NYSE:ACI), Denbury Resources, (NYSE:DNR), Organovo Holdings, (NYSEMKT:ONVO)

On Thursday, Following U.S. Stocks were among the “Top Losers”: Comstock Resources Inc. (NYSE:CRK), Arch Coal Inc. (NYSE:ACI), Denbury Resources Inc. (NYSE:DNR), Organovo Holdings, Inc. (NYSEMKT:ONVO)

Comstock Resources Inc(NYSE:CRK), with shares declined -4.40%, closed at $4.56.

Arch Coal Inc(NYSE:ACI), with shares dropped -4.04%, settled at $0.95.

Denbury Resources Inc.(NYSE:DNR), with shares dipped -3.92%, and closed at $7.60.

Organovo Holdings Inc(NYSEMKT:ONVO), plummeted -3.91%, and closed at $4.42.

Latest NEWS regarding these Stocks are depicted underneath:

Comstock Resources Inc. (NYSE:CRK)

Formerly on March 4, Comstock Resources Inc. (CRK), declared that it has priced $700 million in aggregate principal amount of its 10% senior secured notes due 2020 to be sold to purchasers in a private offering. The notes and the related partner guarantees will be secured by a first priority lien on substantially all of the Corporation`s and its auxiliaries` assets, subject to payment priority in favor of the lenders under a new credit facility described below. Comstock intends to use the net proceeds of the projected offering to retire its existing bank credit facility, with remaining proceeds for general corporate purposes. Comstock anticipates to close the sale of the notes on March 13, 2015, subject to the satisfaction of customary closing conditions. In connection with the pricing of the notes, the Corporation has reached a new $50 million bank revolving credit facility.

The notes were offered in the United States only to qualified institutional buyers following Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons following Regulation S under the Securities Act. The notes have not been registered under the Securities Act or the securities laws of any jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.

Comstock Resources, Inc., an independent energy corporation, attains, develops, explores, and produces oil and natural gas properties in the United States.

Arch Coal Inc. (NYSE:ACI)

Arch Coal Inc. (ACI), has the beta value of 2.50, and its volatility for the week is 8.30%, while for the month it is 8.11%. The company has the market capitalization of $201.66M. The company holds the book value per share of 7.86, whereas cash per share is 4.63. Price to book value is estimated to be 0.12, while price to sale value is 0.21. Analysts mean recommendation for the stock is said to be 3.30. (where 1=Buy, 5=sale).

Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled about 5.1 billion tons of proven and probable recoverable reserves.

Denbury Resources Inc. (NYSE:DNR)

Denbury Resources Inc. (DNR), holds the market capitalization of 2.71B. The stock return on equity value is 11.90%, while return on assets value is 5.20%, in response to its return on investment value of 2.80%. Its 20-day moving average gained -10.18%, below 50-day moving average of -2.55%, below 200-day moving average of -39.46% from the latest market price of $7.60. The mean recommendation of analysts for this stock is 2.80.(where 1=Buy, 5=Sale).

Denbury Resources Inc. operates as an independent oil and natural gas corporation in the United States. The corporation primarily focuses on improved oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region.

Organovo Holdings, Inc. (NYSEMKT:ONVO)

Formerly on March 6, Organovo Holdings, Inc. (ONVO), declared that the March 5th presentation given by President and CEO Keith Murphy is now accessible for on-demand viewing at VirtualInvestorConferences.com.

LINK to the corporation update presentation: http://virtualinvestorconferences.com > red “register / watch presentations here” button.

Organovo’s corporation update presentation will be accessible 24/7 for 90 days. Investors and advisors may download shareholder materials from the “virtual trade booth” for the next three weeks.

Recent Corporation Highlights Comprise:

Named one of The World’s Top 10 Most Innovative Companies of 2015 in Health Care byFast Corporation, a top-tier outlet focused on business and innovation.
Formed partnershipwith Yale School of Medicine to develop 3-D organ tissues for surgical transplantation research
Commercially released the exVive3D™ Liver, Bioprinted Human Tissues for preclinical drug toxicology testing
The exVive3D Liver selected as one of the Top 10 Innovations of 2014 by The Scientistmagazine, a well-respected news outlet for life science researchers
Won the Diagnostics & Research Tools category for the 2014 Most Innovative New Product Awards, sponsored by CONNECT

Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The Corporation develops 3D human disease models through internal development and in partnership with pharmaceutical and academic partners. Organovo’s 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.